Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. - Test2 - elhamkhani - TriplyDB

Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers.

Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers.

http://www.wikidata.org/entity/Q34176503

about

MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer A guide for functional analysis of BRCA1 variants of uncertain significance MicroRNAs and triple negative breast cancer Noncoding RNAs in DNA repair and genome integrity MicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tune Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity Identification of ovarian cancer metastatic miRNAs MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma MicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy Efficacy MicroRNA in breast cancer: The association with BRCA1/2.MicroRNAs in pathogenesis of breast cancer: Implications in diagnosis and treatment.Regulation of angiotensin II type 1 receptor expression in ovarian cancer: a potential role for BRCA1 Low Expression of Circulating MicroRNA-34c is Associated with Poor Prognosis in Triple-Negative Breast Cancer MicroRNA-146a promotes gastric cancer cell apoptosis by targeting transforming growth factor β-activated kinase 1 Deregulation of miR-146a expression in a mouse model of pancreatic cancer affecting EGFR signaling.Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle Increased risk of breast cancer associated with CC genotype of Has-miR-146a Rs2910164 polymorphism in Europeans.The duality of oncomiR addiction in the maintenance and treatment of cancer.BRCA1 pathway function in basal-like breast cancer cells.Selective targeting of KRAS-mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-mutant cells miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition.Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome.The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2.Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 status Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.DNA damage and breast cancer Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis.Revealing the Molecular Portrait of Triple Negative Breast Tumors in an Understudied Population through Omics Analysis of Formalin-Fixed and Paraffin-Embedded Tissues.The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition.Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers Post-transcriptional regulation of BRCA1 through its coding sequence by the miR-15/107 group of miRNAs.Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p MiR-34b is associated with clinical outcome in triple-negative breast cancer patients Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients.

P2860

Q26775086-0BD6203D-A602-4C5B-8B3A-6996C8B53250 Q26829268-1D197992-DFBF-4DED-BBC0-35A607E00CD6 Q26862716-74D16DAF-0A84-41CE-AA55-F48E8A5326B1 Q26864697-14DBB7D4-30F1-4892-9480-DF4399B2E0A5 Q27013740-7A8FE8B8-EFC4-4DEC-AB3D-96C2B9062A47 Q27016123-9AC1D42F-EA79-4D0E-9495-98935B3FD3A9 Q28235715-3080BA06-DC89-4647-A777-4F4E33E9572F Q28299698-091D9B63-31C3-44EA-9A1D-110715154838 Q28487932-C61F84B1-23A8-4948-BE3E-D6E1136F22BE Q28658442-D1989C2C-E229-48B8-806C-E584A3A1DAF4 Q28829013-F6FEC0A1-8A6E-425B-81D6-9C7864455FAD Q33364654-817BD44D-8D26-468B-9D4A-579644DA5BE7 Q33585094-A1EC8262-2CE6-488C-AC14-16066AD7323C Q33644360-DDC627A5-EB51-4856-8F04-46054FDA8E53 Q33734951-9591F7EB-D14E-43AB-9E48-BD6B6B90A814 Q33828286-B8CA9B81-3FE7-46E0-B78F-3C2C002C1976 Q33970228-BECBB9E9-39DA-4774-B24A-1A55B0396E6A Q34052685-794281F7-AFA3-40F5-830E-F749A3900D45 Q34171160-2E55C91F-1429-4A27-9D02-9C444FE25CC1 Q34278112-120D7A69-192F-4006-848B-B6ED91FB6730 Q34297981-840CB0B8-E2AF-4064-8FB4-BED4ECD5C848 Q34365804-6701732D-AE32-4F76-B5AD-B1FB9688C072 Q34380980-E6B1180C-B45A-4516-8B0D-A25682045BAD Q34425208-50691E70-7E31-4DE6-B9DB-EF1097ADCDF3 Q34450694-2C56004B-AD10-43D9-AAE2-5781843FAB94 Q34455481-036DFDA7-3B63-4EFE-BA85-34F5EDA2377D Q34882515-BE818FDA-EB4B-4A7C-8081-47FC66EBFF80 Q35039281-4C6BB65B-9D63-4819-964D-B5B80F2D2ECE Q35078869-97314A76-56E7-4ACD-99A0-6C31D607C283 Q35094742-587238F4-0A18-4FAF-9446-D66963D6DAF5 Q35201664-9C408A14-75A7-4624-8AAC-FAD7EB17DC00 Q35223716-8C3916A0-2592-4BE7-A2FD-665B87EAC995 Q35593154-22BD583E-04AC-40E2-A4DF-2778644A88FD Q35788620-836D7EB0-CA35-43E6-B1EF-592AEE003607 Q35791145-CA25B237-1FE4-430D-ACD2-8C7F4616AFC1 Q35816698-C41E235A-7373-40D8-92FD-7B3187936458 Q35884235-46FA99E8-451F-45CF-A4AC-772876DC8EC8 Q35918018-98DC2009-0B86-4FDF-85FB-B03573C469B8 Q35950656-979DC4C4-9550-470E-BEA7-FC11BBA2D894 Q35955325-89C09320-E7A0-42A4-B6BB-F9DDDF179265

P2860

Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers.

http://www.wikidata.org/entity/Q34176503

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Down-regulation of BRCA1 expre ...... ative sporadic breast cancers.

@ast

Down-regulation of BRCA1 expre ...... ative sporadic breast cancers.

@en

Down-regulation of BRCA1 expre ...... ative sporadic breast cancers.

@nl

type

label

Down-regulation of BRCA1 expre ...... ative sporadic breast cancers.

@ast

Down-regulation of BRCA1 expre ...... ative sporadic breast cancers.

@en

Down-regulation of BRCA1 expre ...... ative sporadic breast cancers.

@nl

prefLabel

Down-regulation of BRCA1 expre ...... ative sporadic breast cancers.

@ast

Down-regulation of BRCA1 expre ...... ative sporadic breast cancers.

@en

Down-regulation of BRCA1 expre ...... ative sporadic breast cancers.

@nl

P1433

Q34176503-5EB458F3-150C-4B42-9D7F-0FB999C8FBDA

P1476

Q34176503-A4202A9B-105F-4AC8-A9BD-86100DE87D6D

P2093

Q34176503-4E08D523-DD1D-4F9B-A916-345B37DE23AF

Q34176503-579A1887-39C2-4512-ACCD-34286ABEDB9A

Q34176503-7862387F-926F-402A-A173-6022C7E81A53

Q34176503-7CBC8E15-34D2-46F9-99FC-D207AA6E5901

Q34176503-C6EFE687-FD26-4307-80F5-B50610ED7320

Q34176503-FFD71C65-29BE-4B1F-AF23-24C60D1145C0

P2860

Q34176503-01B2E81F-0A85-4CF9-87CA-3D2B4F51DD3F

Q34176503-07DF33A7-3C62-4DFF-8FAD-37CCF40CEB22

Q34176503-1315824A-358F-493B-8F96-69B97F6E42CB

Q34176503-15013F13-7730-4011-8F2B-8B84B2C85FB3

Q34176503-1942383B-F013-4CF3-ADC6-E53651CB3B58

Q34176503-1A07CE1B-ADFE-4D42-BF39-6B64F1A65FCF

Q34176503-1EC0010F-CD75-441D-BAD3-755FC06C7ED8

Q34176503-1F51BCE1-F1C5-4698-AFC3-007E990C431C

Q34176503-1F82C2EF-DD75-46A5-9DCE-03466285BE65

Q34176503-21A58345-903B-4C0F-9E4E-A6756713159A

P304

Q34176503-6E6EAD8D-2411-4347-88DD-C686EF1DA6F7

P31

Q34176503-4D483863-1B89-47A7-B722-895EB49AC4B0

P356

Q34176503-9A721368-0274-424B-8CD1-7762766BA48A

P433

Q34176503-B7C3202D-9DAD-4CFB-9377-7B1145467DFF

P478

Q34176503-11F33AA5-5D0C-40EA-9854-0BA5337F34C3

P50

Q34176503-15932FEF-D738-4AD2-8D77-A0F80C26F414

Q34176503-341C550B-AAB6-4A06-A239-9157B318957E

Q34176503-DDF5EE96-59A6-4AE6-B41C-75E4CB1E0702

P577

Q34176503-D88FE243-46B2-4618-B1BF-320758E29DD1

P5875

Q34176503-38F3A01C-8BE7-4562-A0A8-735C59666309

P698

Q34176503-D7DB1FD5-79D8-4031-BA4D-194E4A157F69

P932

Q34176503-48460EBC-0539-47F1-8F1D-A6E98B4B2445

P356

P1433

EMBO Molecular Medicine

P1476

Down-regulation of BRCA1 expre ...... gative sporadic breast cancers

@en

P2093

Amandine I Garcia

http://www.w3.org/2001/XMLSchema#string

Etienne Rouleau

http://www.w3.org/2001/XMLSchema#string

Ivan Mikaélian

http://www.w3.org/2001/XMLSchema#string

Monique Buisson

http://www.w3.org/2001/XMLSchema#string

Rosette Lidereau

http://www.w3.org/2001/XMLSchema#string

Ruth Rimokh

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?

Human MicroRNA targets

Negative Regulation of BRCA1 Gene Expression by HMGA1 Proteins Accounts for the Reduced BRCA1 Protein Levels in Sporadic Breast Carcinoma

Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach

The role of microRNA genes in papillary thyroid carcinoma

A microRNA expression signature of human solid tumors defines cancer gene targets

XRCC3 promotes homology-directed repair of DNA damage in mammalian cells

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

Expression of MicroRNA-146a in osteoarthritis cartilage

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

P304

279-290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201100136

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Pascale Bertrand

P577

2011-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51032243

http://www.w3.org/2001/XMLSchema#string

P698

21472990

http://www.w3.org/2001/XMLSchema#string

P932

3377076

http://www.w3.org/2001/XMLSchema#string